Amgen
PulseAugur coverage of Amgen — every cluster mentioning Amgen across labs, papers, and developer communities, ranked by signal.
3 day(s) with sentiment data
-
AI project overload hinders productivity, experts warn
Companies are launching an overwhelming number of AI projects, which can paradoxically hinder productivity rather than enhance it. Experts suggest that focusing on a few high-impact initiatives and ensuring business-led…
-
FDA Outpaces Pharma with Real-Time AI Clinical Trials
The FDA has successfully implemented a real-time clinical trial data system, allowing for immediate review of patient safety signals. This transformation was driven by the rapid, agency-wide adoption of an AI assistant …
-
OpenAI models, including GPT-5.5, now available on Amazon Bedrock
OpenAI's advanced models, including GPT-5.5 and GPT-5.4, along with the Codex coding agent, are now fully available on Amazon Bedrock. This integration allows businesses to deploy these powerful AI tools into production…
-
Amgen leverages AI to speed up clinical development
Amgen is integrating artificial intelligence into its clinical development processes to accelerate drug discovery and improve trial efficiency. The company is exploring AI for tasks such as identifying patient cohorts, …
-
National IC Fund II cuts Baiwei Storage stake; BeiGene revenue surges 31%
National Integrated Circuit Fund II has reduced its stake in Biwin Storage by 1.85% between February 4th and May 3rd, 2026. This reduction involved selling 8.69 million shares through block and concentrated bidding tran…
-
BeiGene posts Q1 profit of 1.6B yuan on strong drug sales
BeiGene announced its financial results for the first quarter of 2026, reporting a net profit attributable to parent company owners of 1.608 billion yuan. This marks a significant turnaround from a loss in the same peri…
-
FDA pilots real-time AI cloud clinical trials with AstraZeneca and Amgen
The U.S. Food and Drug Administration (FDA) has launched a pilot program utilizing real-time AI and cloud technology for clinical trials. This initiative involves major pharmaceutical companies AstraZeneca and Amgen. Th…